本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Avidity Biosciences, Inc.

26.57
-1.5300-5.44%
盤後26.570.00000.00%19:18 EDT
成交量:184.12萬
成交額:4,936.40萬
市值:31.94億
市盈率:-9.20
高:27.83
開:26.93
低:26.23
收:28.10
資料載入中...
2024/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/12

重要事件披露

Form 8-K - Current report
2024/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/06

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/04

重要事件披露

Form 8-K - Current report
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

重要事件披露

Form 8-K - Current report